Citra-Lock™ 46,7% (trisodium-citrate) Una forma más completa de sellar cualquier catéter.

Citra-Lock™ 46,7% 5ml vial:

1. Antimicrobiano
2. Anticoagulante
3. Anti-biofilm
4. Evita las hemorragias asociadas con la heparina
5. Lower tPa utilization rate and cost
6. Reduces mrsa bloodstream infections
7. Seguro para la trombocitopenia inducida por heparina (pacientes afectados)

Citra-Lock™ (Trisodium citrate 46,7%)

REFERENCES:
1. Winnet G (2008) Trisodium citrate (TSC) 46.7% selectively and safely reduces staphylococcal. Nephrol Dial Transplant 10: 1093-1100
2. Weijmer MC (2005) Randomized, Clinical Trial Comparison of Trisodium Citrate 30% and Heparin as Catheter-Locking Solution in Haemodialysis Patients.
J Am Soc Nephrol. Sep;16(9):2769-77
3. Weijmer MC (2002) Superior Antimicrobial Activity of Trisodium Citrate over Heparin for Catheter Locking. Nephrol Dial Transplant 17: 2189-2195
4. Shanks RM (2006) Catheter Lock Solutions Influence Staphylococcal Biofilm Formation on Abiotic Surfaces. Nephrol Dial Transplant 21, 2247-2255
5. Ash SR (2000) Concentrated Sodium Citrate (23%) for Catheter Lock. Haemodialysis International 4:22-31
6. Nolan JP (2007) Reducing Catheter Related Bacteraemia in Haemodialysis. Vascular Access Soc. 5th Int. Congress of Vascular Access Soc, Nice

Also Available:
Citra-Lock™ 4%
Citra-Flow™ 4%
Citra-Lock™ 30%

Citra-Lock™ and Citra-Flow™ are registered as a medical device (Class IIb)